# Enginprime Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enginprime-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $15M
- Latest round: Series A (Aug 17, 2026)
- Investors on record: 1

## About

Founded in 2023 and based in Shanghai, China, Shanghai Anlan Dejian Medical Device Co., Ltd., trading as Enginprime Medical, is a cardiovascular and cerebrovascular disease solutions provider. In August 2026,?Enginprime Medical raised?USD 12 million?in?series A funding?led by Qiming Venture Partners.?

The company is focusing on the research and development and transformation of innovative medical technologies in the cardiovascular field, with a focus on the percutaneous ventricular assist device (VAD) track and committed to developing a new generation of small-size, high-flow VAD systems.

The company's revenue is generated by providing cardiovascular and cerebrovascular disease solutions.

The company will use the August 2026 funding to advance the clinical development, regulatory approval, and commercialization of its OpusOne cardiac assist device platform.

## Funding rounds

- Series A, Aug 17, 2026, $15M — Qiming Venture Partners

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A